Periodic Reporting for period 1 - OptiViVax (Optimising a High Efficacy Plasmodium vivax Malaria Vaccine)

Plasmodium vivax is the most widespread human malaria with 2.5 billion people living at risk in Africa, South America, Oceania and Asia. The revised Malaria Vaccine Technology Roadmap to 2030 recognises the severity of P. vivax malaria, calling for a vaccine intervention to...